Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDNA · against 222 other Healthcare companies of similar size
Ranked #41 of 223 · scores higher than 81% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 80–89, including CDNA · Click a bar to see the companies
Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | CDNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 222 reported | 34.4% | 8.1% | 84% | 33% | |
| Earnings per share growthHigher is better · 142 reported | 96.5% | 9.7% | 88% | 33% | |
| 3-year revenue growthHigher is better · 216 reported | 14.0% | 8.9% | 67% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 40 | 5.1B USD | 85 | 52 | |
| 41 | 23.0B CNY (≈$3.2B) | 84 | 64 | |
| 41 | 3.9B USD | 84 | 47 | |
| 41 | 40.3B SEK (≈$4.0B) | 84 | 79 | |
| 41 | 4.6B USD | 84 | 65 | |
| 45 | 18.3B CNY (≈$2.6B) | 83 | 80 | |
| 45 | 4.1B USD | 83 | 39 | |
| 45 | 3.1B USD | 83 | 53 | |
| 45 | 4.2B USD | 83 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score